OptimizeRx (NASDAQ:OPRX) reported quarterly earnings of $0.16 per share which beat the analyst consensus estimate of $0.12 by 33.33 percent. This is a 33.33 percent decrease over earnings of $0.24 per share from the same period last year. The company reported quarterly sales of $20.504 million which beat the analyst consensus estimate of $20.204 million by 1.49 percent. This is a 29.77 percent decrease over sales of $29.195 million the same period last year.